Standard precautions: what is meant and what is not

E.T. Curran^*
*NHS National Services Scotland, Health Protection Scotland, UK
Journal of Hospital Infection (2015) 90, 10-11
No abstract.
サマリー原文（英語）はこちら
監訳者コメント：
英国ではカルバペネム分解酵素産生菌の感染対策にからみ、標準予防策とは何かの記載について、WHO と CDC、スコットランド地方の保健当局ならびに英国のエビデンスに基づく感染予防ガイドライン（epic3 プロジェクト）との間で食い違いがあり混乱を招いていると指摘、概念の統一性と今後の進歩に期待を寄せている。

Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2

K. Steinhauer*, T.L. Meister, D. Todt, A. Krawczyk, L. Paßvogel, B. Becker, D. Paulmann, B. Bischoff, M. Eggers, S. Pfaender, F.H.H. Brill, E. Steinmann

*Schülke & Mayr GmbH, Germany

Journal of Hospital Infection (2021) 112, 27-30

Modelling interventions and contact networks to reduce the spread of carbapenem-resistant organisms between individuals in the ICU

D.A. Martínez*, J. Cai, G. Lin, K.E. Goodman, R. Paul, J. Lessler, S.R. Levin, M. Toerper, P.J. Simner, A.M. Milstone, E.Y. Klein, on behalf of the MInD-Healthcare
*Pontificia Universidad Católica de Valparaíso, Chile

Journal of Hospital Infection (2023) 136, 1-7

Risk of multi-drug-resistant organism acquisition from prior bed occupants in the intensive care unit: a meta-analysis

G.Y. Gu*, M. Chen, J.C. Pan, X.L. Xiong
*The Affiliated BenQ Hospital of Nanjing Medical University, China

Journal of Hospital Infection (2023) 139, 44-55

Prevalence, incidence, and risk factors of urinary tract infection among immobile inpatients in China: a prospective, multi-centre study

Identifying hospital-acquired infections using retrospective record review from the Irish National Adverse Events Study (INAES) and European point prevalence survey case definitions